MAOA and Parkinson disease: Inhibitors of MAO-A are clinically used as antidepressants and anxiolytics [22,23], while MAO-B inhibitors are used in the treatment of Parkinson’s disease and in the management of symptoms associated with Alzheimer’s disease [24].